Dube Eric M: insider trades.
Dube Eric M reported 11 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 8 sales ($25.4M), across 1 company.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 8
- Companies
- 1
- Name as filed
- Dube Eric M
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | Director, Officer · CHIEF EXECUTIVE OFFICER | 11 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-17 | Travere Therapeutics, Inc. | S | 6,802 | $64.95 | 432,886 | Form 4 |
| 2026-09-17 | Travere Therapeutics, Inc. | M | 108,493 | $23.34 | 541,379 | Form 4 |
| 2026-09-17 | Travere Therapeutics, Inc. | S | 101,691 | $64.59 | 439,688 | Form 4 |
| 2026-09-16 | Travere Therapeutics, Inc. | S | 99,716 | $63.26 | 529,011 | Form 4 |
| 2026-09-16 | Travere Therapeutics, Inc. | S | 96,125 | $63.64 | 432,886 | Form 4 |
| 2026-09-16 | Travere Therapeutics, Inc. | M | 195,841 | $23.34 | 628,727 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | M | 95,666 | $23.34 | 528,552 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 63,498 | $61.99 | 465,054 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 28,796 | $62.66 | 436,258 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 3,102 | $63.64 | 433,156 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 270 | $65.31 | 432,886 | Form 4 |
Questions
What stock did Dube Eric M buy or sell?
Dube Eric M reported 11 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 8 sales ($25.4M), across 1 company.
Is Dube Eric M the same person as other filers with this name?
This page covers SEC CIK 1763494 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/dube-eric-m-1763494.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.